Ondrej Hrusak Selected Research

Ondrej Hrusak Research Topics

11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2005
4	Residual Neoplasm 01/2021 - 01/2013
4	Leukemia 01/2018 - 06/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 06/2010
1	Disease Progression 01/2022
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022
1	Enteritis 01/2022
1	Fever (Fevers) 01/2022
1	Vascular Skin Diseases 01/2022
1	Infections 01/2022
1	Central Nervous System Vasculitis 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Obesity 01/2020
1	COVID-19 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Brain Neoplasms (Brain Tumor) 05/2019
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019
1	Neoplasms (Cancer) 11/2018
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 11/2018
1	Pancytopenia 03/2016
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 03/2016
1	Sepsis (Septicemia) 03/2016
1	Polyneuropathies (Polyneuropathy) 03/2016
1	Trisomy (Trisomies) 01/2016

3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 01/2013
2	blinatumomabIBA 01/2022 - 01/2021
2	Biological ProductsIBA 01/2019 - 04/2005
2	AntigensIBA 01/2018 - 04/2005
2	Proteins (Proteins, Gene)FDA Link 04/2016 - 08/2011
1	Toll-Like Receptor 8IBA 01/2022
1	Janus Kinase 1IBA 01/2022
1	ruxolitinibIBA 01/2022
1	src-Family KinasesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	SmokeIBA 01/2020
1	SuspensionsIBA 05/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2018
1	alanyl-leucyl-alanyl-leucine (ALAL)IBA 01/2018
1	Antigen Receptors (Antigen Receptor)IBA 01/2017
1	Vincristine (Oncovin)FDA LinkGeneric 03/2016
1	Protein Isoforms (Isoforms)IBA 03/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	drebrinsIBA 08/2011
1	Monoclonal AntibodiesIBA 08/2011
1	Immunoglobulins (Immunoglobulin)IBA 06/2010

5	Therapeutics 01/2022 - 06/2010
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
2	Consolidation Chemotherapy 01/2022 - 01/2021
1	Ligation 03/2013
1	Aftercare (After-Treatment) 01/2013